NA Tender by Employees State Insurance Corporation (esic) (GEM/2025/B/6045638)
Acellular Dermal Matrix (V3)
Tender Timeline
Tender Title: Acellular Dermal Matrix (V3)
Tender Reference Number: GEM/2025/B/6045638
Issuing Authority/Department: Ministry of Labour and Employment
Scope of Work and Objectives
The Acellular Dermal Matrix (V3) tender aims to procure high-quality acellular dermal matrices that will be utilized in various medical procedures. The objective is to provide healthcare institutions with reliable and effective materials that enhance patient outcomes in surgeries and other medical interventions. The tender invites qualified suppliers to submit their bids, ensuring competitive pricing while maintaining high standards of quality.
Eligibility Criteria
Participants in this tender must fulfill specific eligibility requirements, including being a registered entity capable of supplying medical products. Interested bidders should possess relevant experience in the medical sector, specifically in the supply of dermal matrices. Compliance with health and safety regulations is essential.
Technical Requirements
Bidders are required to provide detailed information about the technical specifications of the Acellular Dermal Matrix (V3). This includes compliance with industry standards, quality certifications, product dimensions, and any unique features that differentiate the matrix from other available products in the market.
Financial Requirements
All bidders must demonstrate their financial capability to fulfill the order through appropriate documentation. This includes submission of pricing structures and terms. The ability to provide competitive pricing while ensuring quality will play a significant role in the evaluation process.
Document Submission Details
All submission documents must be compiled digitally and submitted in the prescribed formats as detailed in the tender guidelines. Bidders should ensure that all required documentation accompanies their submissions to avoid disqualification. Late submissions will not be entertained.
Special Provisions
The tender gives favorable consideration to Micro, Small, and Medium Enterprises (MSEs). Startups that meet the eligibility criteria are also encouraged to submit their bids, aligning with the government's initiatives to promote local manufacturing and innovation.
Evaluation Process
The evaluation of bids will be conducted with a focus on the technical specifications, financial offerings, and compliance with health standards. The evaluation process aims to identify suppliers capable of meeting the volume and quality required for healthcare applications.
Delivery Locations
Successful bidders will be required to deliver the Acellular Dermal Matrix to designated healthcare facilities as specified in the tender documents. Timely delivery is critical to ensure that medical procedures reliant on these materials are not delayed.
Contact Information
For any clarifications or additional information regarding this tender, interested parties can reach out to the Ministry of Labour and Employment. However, details such as email or phone numbers are not provided in this documentation.
Overall, the Acellular Dermal Matrix (V3) tender presents a valuable opportunity for suppliers to engage with a critical sector while adhering to quality and compliance standards.
General Information
Financial Information
Evaluation and Technical Information
Tender Documents
4 DocumentsDocuments Required from Seller
- Experience Criteria
- Past Performance
- Bidder Turnover
- Certificate (Requested in ATC)
- OEM Authorization Certificate
- OEM Annual Turnover
- Additional Doc 1 (Requested in ATC) *In case any bidder is seeking exemption from Experience / Turnover Criteria
- the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Corrigendum Updates
Similar Tenders
Frequently Asked Questions
The eligibility requirements for participating in the tender include being a registered entity with expertise in supplying medical products. Bidders must have prior experience in the healthcare sector and adhere to relevant health and safety regulations. Additionally, they should possess the capability to supply the required quality of Acellular Dermal Matrix to healthcare institutions.
Participants must provide relevant certificates that demonstrate compliance with industry standards, including ISO certifications and other quality assurance documentation. These certifications should validate the safety and efficacy of the Acellular Dermal Matrix products offered in the bid, ensuring they meet the regulatory requirements for medical use.
Bidders are required to submit their documents digitally through the specified online platform. All documents must be submitted in the accepted formats, as outlined in the tender guidelines. Failure to adhere to these submission methods and formats can result in disqualification. It’s critical to ensure that all required documentation is complete and submitted by the deadline.
Payment terms typically involve an initial advance payment followed by milestone payments upon successful delivery and acceptance of the products. Detailed payment terms can be found within the tender documentation. Bidders should ensure their proposals align with these terms to facilitate smooth transactions upon contract award.
Yes, the Acellular Dermal Matrix (V3) tender has specific provisions designed to support Micro, Small, and Medium Enterprises (MSEs). By encouraging bids from MSEs, the tender aligns with government initiatives aimed at promoting local manufacturing and increasing competitiveness. This not only enhances opportunities for small businesses but also contributes to the sustainability of local economies.
Probable Bidders
Get Tender Alerts
Get notifications for similar tenders